'Vaccine manufacturers' presentation slideshows

A Second Look At Vaccinations: The Risks and Dangers

A Second Look At Vaccinations: The Risks and Dangers. A Special Report. Young Living Grand Convention, June 18-21, 2002. A Second Look at Vaccinations: The Risks and Dangers A Special Report

815 views • 68 slides

Canine Influenza Virus

Canine Influenza Virus. Wendy Blount, DVM. Kennel Cough. A low level of upper respiratory infection is common at any shelter or kennel Vaccine not available for all pathogens (KC, PI, CAV2, flu) Vaccines do not prevent infection, they just mitigate severity of disease

1.05k views • 53 slides

630 views • 41 slides

THE NATIONAL INFLUENZA VACCINE SUMMIT: UPDATE

1.02k views • 18 slides

Rakesh Pandey, Ph.D. Division of Vaccines and Related Products Applications/OVRR/CBER/FDA

Vaccines and Related Biological Products Advisory Committee 18 February 2009 Topic 2: Considerations and Implications for adding two B Strains to the Seasonal Influenza Vaccine. Rakesh Pandey, Ph.D. Division of Vaccines and Related Products Applications/OVRR/CBER/FDA. INTRODUCTION.

488 views • 12 slides

Norman W. Baylor, Ph.D. Director, Office of Vaccines Research and Review FDA/CBER 23 July 2009

VACCINES AND RELATED BIOLOGICAL PRODUCTS ADVISORY COMMITTEE FDA Regulatory Pathway To Facilitate the Licensure and Availability of Pandemic (H1N1) 2009 Influenza Virus Vaccines. Norman W. Baylor, Ph.D. Director, Office of Vaccines Research and Review FDA/CBER 23 July 2009. Introduction.

290 views • 12 slides

A PROGRESS REPORT ON CDC EFFORTS TO ESTABLISH A COMPREHENSIVE PEDIATRIC VACCINE STOCKPILE

A PROGRESS REPORT ON CDC EFFORTS TO ESTABLISH A COMPREHENSIVE PEDIATRIC VACCINE STOCKPILE. A PRESENTATION TO NVAC JUNE 3, 2003. Dean Mason Chief, Program Support Branch NIP/ISD. BACKGROUND & RATIONALE. NIP has contracted for a limited number of stockpile vaccines since 1983

143 views • 6 slides